Literature DB >> 19288273

Nerve growth factor of red nucleus involvement in pain induced by spared nerve injury of the rat sciatic nerve.

Yuan-Yuan Jing1, Jun-Yang Wang, Xiao-Li Li, Zhi-Hong Wang, Liu Pei, Ming-Ming Pan, Xiao-Ping Dong, Gui-Xiang Fan, Yu-Kang Yuan.   

Abstract

Nerve growth factor (NGF), a member of the neurotrophin family, is essential for the development and maintenance of sensory neurons and for the formation of central pain circuitry. The current study was designed to evaluate the expression of NGF in the brain of rats with spared nerve injury (SNI), using immunohistochemical technique. The results showed that the level of NGF in the Red nucleus (RN) of SNI rats was apparently higher than that of sham-operated rats. To further study the effect of NGF in the development of neuropathic pain, different doses of anti-NGF antibody (20, 2.0 and 0.2 microg/ml) were microinjected into the RN contralateral to the nerve injury side of SNI rats. The data suggested that the higher doses of anti-NGF antibody (20 and 2.0 microg/ml) significantly attenuated the mechanical allodynia of neuropathic rats, while the 0.2 microg/ml antibody showed no analgesic effect. These results suggest that the NGF of RN is involved in the development of neuropathic allodynia in SNI rats.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19288273     DOI: 10.1007/s11064-009-9950-7

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  28 in total

1.  [The analgesic effect of red nucleus and preliminary research on its mechanism].

Authors:  M Huang; M Liu; X Li
Journal:  Zhen Ci Yan Jiu       Date:  1992

Review 2.  The nerve growth factor 35 years later.

Authors:  R Levi-Montalcini
Journal:  Science       Date:  1987-09-04       Impact factor: 47.728

3.  Efficient analysis of experimental observations.

Authors:  W J Dixon
Journal:  Annu Rev Pharmacol Toxicol       Date:  1980       Impact factor: 13.820

4.  Adrenergic innervation of rat sensory ganglia following proximal or distal painful sciatic neuropathy: distinct mechanisms revealed by anti-NGF treatment.

Authors:  M S Ramer; M A Bisby
Journal:  Eur J Neurosci       Date:  1999-03       Impact factor: 3.386

5.  Effect of NGF and anti-NGF on neuropathic pain in rats following chronic constriction injury of the sciatic nerve.

Authors:  L S Ro; S T Chen; L M Tang; J M Jacobs
Journal:  Pain       Date:  1999-02       Impact factor: 6.961

6.  Quantitative assessment of tactile allodynia in the rat paw.

Authors:  S R Chaplan; F W Bach; J W Pogrel; J M Chung; T L Yaksh
Journal:  J Neurosci Methods       Date:  1994-07       Impact factor: 2.390

7.  Descending systems contributing to locomotor recovery after mild or moderate spinal cord injury in rats: experimental evidence and a review of literature.

Authors:  D Michele Basso; Michael S Beattie; Jacqueline C Bresnahan
Journal:  Restor Neurol Neurosci       Date:  2002       Impact factor: 2.406

8.  The biological effects of endogenous nerve growth factor on adult sensory neurons revealed by a trkA-IgG fusion molecule.

Authors:  S B McMahon; D L Bennett; J V Priestley; D L Shelton
Journal:  Nat Med       Date:  1995-08       Impact factor: 53.440

9.  Studies on carrageenan-induced arthritis in adult rats: presence of nerve growth factor and role of sympathetic innervation.

Authors:  L Aloe; M A Tuveri; R Levi-Montalcini
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

10.  Nerve growth factor administration protects against experimental diabetic sensory neuropathy.

Authors:  S C Apfel; J C Arezzo; M Brownlee; H Federoff; J A Kessler
Journal:  Brain Res       Date:  1994-01-14       Impact factor: 3.252

View more
  7 in total

1.  Alterations in resting state oscillations and connectivity in sensory and motor networks in women with interstitial cystitis/painful bladder syndrome.

Authors:  Lisa A Kilpatrick; Jason J Kutch; Kirsten Tillisch; Bruce D Naliboff; Jennifer S Labus; Zhiguo Jiang; Melissa A Farmer; A Vania Apkarian; Sean Mackey; Katherine T Martucci; Daniel J Clauw; Richard E Harris; Georg Deutsch; Timothy J Ness; Claire C Yang; Kenneth Maravilla; Chris Mullins; Emeran A Mayer
Journal:  J Urol       Date:  2014-03-26       Impact factor: 7.450

2.  The Red Nucleus TNF-α Participates in the Initiation and Maintenance of Neuropathic Pain Through Different Signaling Pathways.

Authors:  Qian Zhang; Jing Yu; Jing Wang; Cui-Ping Ding; Shui-Ping Han; Xiao-Yan Zeng; Jun-Yang Wang
Journal:  Neurochem Res       Date:  2015-05-08       Impact factor: 3.996

3.  Melatonin Alters the Mechanical and Thermal Hyperalgesia Induced by Orofacial Pain Model in Rats.

Authors:  Vanessa Leal Scarabelot; Liciane Fernandes Medeiros; Carla de Oliveira; Lauren Naomi Spezia Adachi; Isabel Cristina de Macedo; Stefania Giotti Cioato; Joice S de Freitas; Andressa de Souza; Alexandre Quevedo; Wolnei Caumo; Iraci Lucena da Silva Torres
Journal:  Inflammation       Date:  2016-10       Impact factor: 4.092

4.  Interleukin-10 of red nucleus plays anti-allodynia effect in neuropathic pain rats with spared nerve injury.

Authors:  Zhi-Hong Wang; Xiao-Yan Zeng; Shui-Ping Han; Gui-Xiang Fan; Jun-Yang Wang
Journal:  Neurochem Res       Date:  2012-05-15       Impact factor: 3.996

5.  Role of neurotrophins in neuropathic pain.

Authors:  Dario Siniscalco; Catia Giordano; Francesco Rossi; Sabatino Maione; Vito de Novellis
Journal:  Curr Neuropharmacol       Date:  2011-12       Impact factor: 7.363

6.  Effect of melatonin supplemented at the light or dark period on recovery of sciatic nerve injury in rats.

Authors:  Enas Ezzat Rateb; Shaimaa Nasr Amin; Nashwa El-Tablawy; Laila Ahmed Rashed; Samah El-Attar
Journal:  EXCLI J       Date:  2017-03-06       Impact factor: 4.068

7.  Detection of local and remote cellular damage caused by spinal cord and peripheral nerve injury using a heat shock signaling reporter system.

Authors:  Kazue Hashimoto-Torii; Masanori Sasaki; Yu-Wen Chang; Hye Hwang; Stephen G Waxman; Jeffery D Kocsis; Pasko Rakic; Masaaki Torii
Journal:  IBRO Rep       Date:  2018-11-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.